Strides Pharma Science share news, announcements and annual reports
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Strides Pharma Science Limited · Formerly Strides Shasun · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000 on NSE, Jun 2004 on BSE
Last close ₹1,036.90down ₹31.90 (2.98%)BSE ₹1,037.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,068.80.
2 Nov: open ₹1,067.30, high ₹1,067.30, low ₹1,013.90
52-week range of traded prices to 2 Nov 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,557 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,07,98637.7% delivered
Strides Pharma Science orders, deals and press releases
485 filed, newest first. Page 6 of 10.
May 2015
Apr 2015
Mar 2015
Feb 2015
Jan 2015
Dec 2014
Nov 2014
Oct 2014
Sep 2014
Aug 2014
Jul 2014
Jun 2014
May 2014
Apr 2014
Feb 2014
Dec 2013
19 Dec · Business
Company has allotted 280,000 fully paid equity shares of Rs.10/- each on conversion of employee stock options under the Company's Employee Stock Option Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 592,856,210/- consisting of 59,285,621 equity shares of Rs. 10/- each to Rs. 595,656,210/- consisting of 59,565,621 equity shares of Rs. 10/- each.9 Dec · Business
Company has allotted 123,000 fully paid equity shares of Rs.10/- each under the Strides Arcolab ESOP 2006 and ESOP 2008 Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 591,626,210/- consisting of 59,162,621 equity shares of Rs. 10/- each to Rs. 592,856,210/- consisting of 59,285,621 equity shares of Rs. 10/- each.
Nov 2013
Oct 2013
17 Oct · Business
Company has allotted 1,250 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 591,613,710/- consisting of 59,161,371 equity shares of Rs. 10/- each to Rs. 591,626,210/- consisting of 59,162,621 equity shares of Rs. 10/- each.
Sep 2013
27 Sep · Business
Company has allotted 51,250 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 591,101,210/- consisting of 59,110,121 equity shares of Rs. 10/- each to Rs. 591,613,710/- consisting of 59,161,371 equity shares of Rs. 10/- each.
Aug 2013
28 Aug · Business
Company has allotted 10,000 fully paid equity shares of Rs.10/- each under Strides Arcolab ESOP 2008 (Director) Scheme to Non-Executive Directors of the Company. Consequent to the allotment, the paid-up equity share capital of the Company has increased from Rs. 591,001,210/- consisting of 59,100,121 equity shares of Rs. 10/- each to Rs. 591,101,210/- consisting of 59,110,121 equity shares of Rs. 10/- each.
Jul 2013
11 Jul · Business
Company has allotted 50,000 fully paid equity shares of Rs.10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme.Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 590,501,210/- consisting of 59,050,121 equity shares of Rs. 10/- each to Rs. 591,001,210/- consisting of 59,100,121 equity shares of Rs. 10/- each.
Jun 2013
20 Jun · Business
Company has allotted 1800 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP 2008 Scheme. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 590,483,210/- consisting of 59,048,321 equity shares of Rs. 10/- each to Rs. 590,501,210/- consisting of 59,050,121 equity shares of Rs. 10/- each.
Apr 2013
Mar 2013
13 Mar · Business
Company has allotted 42,150 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 590,061,710/- consisting of 59,006,171 equity shares of Rs. 10/- each to Rs. 590,483,210/- consisting of 59,048,321 equity shares of Rs. 10/- each.1 Mar · Business
Company has allotted 120,800 fully paid equity shares of Rs. 10/- each on conversion of employee stock options under Strides Arcolab ESOP Schemes. Consequent to the above allotment, the paid-up equity share capital of the Company has increased from Rs. 588,037,210/- consisting of 58,803,721 equity shares of Rs. 10/- each to Rs. 589,245,210/- consisting of 58,924,521 equity shares of Rs. 10/- each.
Feb 2013